Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

E-MTAB-8482

ABSTRACT: RNA Sequencing of CD169+ lymph node macrophages isolated from nave or tumor-bearing mice

PROVIDER: E-MTAB-8482 | ExpressionAtlas | 2020-01-13

REPOSITORIES: ExpressionAtlas

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	E-MTAB-8482-analysis-methods.tsv	Tabular
	E-MTAB-8482-analytics.tsv	Tabular
	E-MTAB-8482-atlasExperimentSummary.Rdata	Rdata
	E-MTAB-8482-configuration.xml	Xml
	E-MTAB-8482-g2_g1-mvaPlot.png	Other

Items per page:

1 - 5 of 34

Similar Datasets

E-MTAB-6451

Project description:RNA-seq of total lymph node cells from inducible ll7 gene deletion mice

2018-06-04 | E-MTAB-6451 | ExpressionAtlas

E-MTAB-8255

Project description:RNA-Seq of lymph node fibroblastic reticular cells isolated from bone marrow transplant recipient mice with or without acute Graft-versus-host disease on day 7 or untransplanted control mice

2019-09-09 | E-MTAB-8255 | ExpressionAtlas

RNA Sequencing of CD169+ lymph node macrophages isolated from naïve or tumor-bearing mice

Project description:RNA Sequencing of CD169+ lymph node macrophages isolated from naïve or tumor-bearing mice

| PRJEB35312 | ENA

E-MTAB-6632

Project description:Expression data from draining lymph node and muscle of mice immunised with AS03 or PBS

2018-04-05 | E-MTAB-6632 | ExpressionAtlas

E-MTAB-5032

Project description:RNA-seq analysis of normoxic and hypoxic tumor-associated macrophages from wild type or REDD1 knockout mice

2019-05-14 | E-MTAB-5032 | ExpressionAtlas

Gene expression signatures for B cells from tumor draining lymph node and normal lymph node

Project description:To determine the different gene signatures between B lymphocytes from tumor draining lymph node (DLN) and normal lymph node (NLN), we have employed gene microarray as a discovery platform to identify gene signatures of tumor-educated B cells in DLN from tumor-bearing mice, taking NLN from normal mice as a control. We subcutaneously inoculated Balb/c mice with breast cancer cell line 4T1. Two weeks later, DLN was harvest and B cells were purified as descript in “treatment protocol”. From gene microarray, we found that B cells in DLN showed quite different transcript profiles from that in NLN.

2018-05-01 | GSE81146 | GEO

E-MTAB-7897

Project description:RNA-Seq of human lymph node stromal cells during the earliest phases of rheumatoid arthritis

2025-01-23 | E-MTAB-7897 | ExpressionAtlas

PD-L1 regulates dendritic cell ferroptosis during immunogenic chemotherapy [scRNA-seq]

Project description:Dendritic cells (DCs) express high levels of PD-L1 in the tumor microenvironment and draining lymph nodes. Here, we explore the roles of PD-L1 signaling during immunogenic chemotherapy. DC-conditional PD-L1 knockout mice were inoculated with MC38-OVA tumors and treated with doxorubicin. T cells were isolated from draining lymph node for single cell RNA sequencing.

2024-09-23 | GSE223509 | GEO

Melanoma-derived small extracellular vesicles induce lymphangiogenesis and metastasis by a NGFR-dependent mechanism

Project description:Secreted extracellular vesicles are known to influence the tumor microenvironment and promote metastasis. In this work, we have analyzed the involvement of extracellular vesicles in establishing the lymph node pre-metastatic niche by melanoma cells. We found that small extracellular vesicles (sEVs) derived from highly metastatic melanoma cell lines spread broadly through the lymphatic system and are taken up by lymphatic endothelial cells reinforcing lymph node metastasis. Melanoma-derived sEVs induce lymphangiogenesis, a hallmark of pre-metastatic niche formation, in vitro and in lymphoreporter mice in vivo. Analysis of involved factors demonstrated that the neural growth factor receptor (NGFR) is secreted in melanoma-derived small extracellular vesicles and shuttled to lymphatic endothelial cells inducing lymphangiogenesis and tumor cell adhesion through the activation of ERK and NF-B pathways and ICAM1 expression. Importantly, ablation or inhibition of NGFR in sEVs reversed the lymphangiogenic phenotype, decreased melanoma lymph node metastasis and extended mice survival. Importantly, analysis of NGFR expression in lymph node metastases and matched primary tumors shows that levels of MITF+NGFR+ lymph node metastatic cells are correlated with disease outcome. Our data support that NGFR is secreted in sEVs favoring lymph node pre-metastatic niche formation and lymph node metastasis in melanoma.

2021-07-16 | PXD024108 | Pride

E-GEOD-44408

Project description:Transcriptomic survey of lymph node-positive vs. - negative ductal breast cancer

2025-01-24 | E-GEOD-44408 | ExpressionAtlas